Intra-Cellular Therapies Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	617.34	178	115.65	67.49	71.35
Other Revenue	-	-	7.01	-	-
Revenue	617.34	178	122.66	67.49	71.35
Revenue Growth (YoY)	246.82%	45.12%	81.76%	-5.42%	-
Cost of Revenue	495.71	146.29	106.1	61.6	65.72
Gross Profit	121.63	31.71	16.56	5.89	5.63
Selling, General & Admin	14.8	5.52	1.12	1.49	2.5
Other Operating Expenses	17.97	3.53	1.82	2.17	0.84
Operating Expenses	32.96	9.12	2.99	3.73	3.51
Operating Income	88.67	22.59	13.57	2.16	2.12
Interest Expense	-2.12	-0.63	-0.33	-	-
Interest & Investment Income	-	0.3	0	0.03	0.05
Other Non Operating Income (Expenses)	0.8	-0.3	-0.07	-0.01	-0.02
EBT Excluding Unusual Items	87.35	21.97	13.18	2.18	2.14
Gain (Loss) on Sale of Assets	-	-	-	0.01	-
Pretax Income	87.35	21.97	13.18	2.18	2.14
Income Tax Expense	24.03	6.08	-	-	-
Net Income	63.31	15.89	13.18	2.18	2.14
Net Income to Common	63.31	15.89	13.18	2.18	2.14
Net Income Growth	298.46%	20.57%	503.39%	1.91%	-
Shares Outstanding (Basic)	5	3	3	-	-
Shares Outstanding (Diluted)	5	3	3	-	-
Shares Change (YoY)	87.69%	-17.36%	-	-	-
EPS (Basic)	12.91	5.57	3.82	-	-
EPS (Diluted)	11.83	5.57	3.82	-	-
EPS Growth	112.30%	45.89%	-	-	-
Free Cash Flow	-4.77	-39.05	3.07	-1.6	-0.81
Free Cash Flow Per Share	-0.89	-13.70	0.89	-	-
Gross Margin	19.70%	17.82%	13.50%	8.73%	7.89%
Operating Margin	14.36%	12.69%	11.06%	3.21%	2.97%
Profit Margin	10.26%	8.93%	10.74%	3.24%	3.00%
Free Cash Flow Margin	-0.77%	-21.94%	2.50%	-2.37%	-1.13%
EBITDA	88.86	22.67	13.62	2.23	2.28
EBITDA Margin	14.39%	12.73%	11.11%	3.30%	3.19%
D&A For EBITDA	0.19	0.08	0.05	0.07	0.16
EBIT	88.67	22.59	13.57	2.16	2.12
EBIT Margin	14.36%	12.69%	11.06%	3.21%	2.97%
Effective Tax Rate	27.52%	27.66%	-	-	-
Revenue as Reported	618.14	178.31	122.66	67.52	71.4
Advertising Expenses	-	-	0.06	0.02	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.